Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1110 | 935 | 1193 | 1213 | 1555 | 2237 |
Fund Return | 11.02% | -6.47% | 19.33% | 6.65% | 9.23% | 8.39% |
Place in category | 135 | 396 | 118 | 20 | 28 | 48 |
% in Category | 11 | 44 | 10 | 2 | 6 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Balanced Fund A USD Acc | 8.85B | 16.20 | 3.74 | 7.13 | ||
Janus Balanced Fund I USD Acc | 8.85B | 17.30 | 4.82 | 8.18 | ||
Janus Global Life Sciences Fund A U | 3.92B | 10.19 | 5.78 | 7.55 | ||
Janus Global Technology Fund A USD | 534.51M | 31.84 | 7.00 | 16.96 | ||
Janus Global Technology Fund I USD | 534.51M | 32.84 | 7.89 | 17.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund A U | 3.92B | 10.19 | 5.78 | 7.55 | ||
Wellington Global Health Care EquiS | 2.09B | 5.65 | -0.46 | 7.96 | ||
Wellington Global Health Care EquiD | 2.09B | 4.56 | 0.72 | 6.80 | ||
Wellington Global Health Care EquUG | 2.09B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiN | 2.09B | 5.18 | 1.37 | 7.49 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.62 | 778.62 | -0.05% | |
UnitedHealth | US91324P1021 | 6.78 | 485.52 | -2.60% | |
Novo Nordisk B | DK0062498333 | 4.46 | 767.0 | -0.38% | |
AbbVie | US00287Y1091 | 3.79 | 175.38 | +2.18% | |
AstraZeneca | GB0009895292 | 3.52 | 10,444.0 | -0.59% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review